Skip to main content
. 2020 Dec 4;40(7):2593–2600. doi: 10.1007/s10067-020-05512-7

Table 2.

Research agenda

Education
○ Establishment of consensual training requirements
○ Development of a training framework and practical opportunities
Clinical applications
○ Development and implementation of synovial tissue biomarkers for diagnosis or prognosis for RMDs in clinical practice
Translational research
○ Synovial tissue atlas (multi-omics approach) in RMDs
○ Assessment of tissular miRNA signature through single-cell approaches (single-cell miRNome) in RMDs
Quality appraisal of research
○ EULAR points to consider for minimal reporting requirements in synovial tissue clinical practice and research in rheumatology
Therapy
○ Personalized medicine and sequential therapy in RMDs
○ Synovial cells reprogramming